These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24121959)

  • 21. Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients.
    Choo IH; Ni R; Schöll M; Wall A; Almkvist O; Nordberg A
    J Alzheimers Dis; 2013; 33(4):929-39. PubMed ID: 23047371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
    López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
    J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
    Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
    Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study.
    Ito K; Fukuyama H; Senda M; Ishii K; Maeda K; Yamamoto Y; Ouchi Y; Ishii K; Okumura A; Fujiwara K; Kato T; Arahata Y; Washimi Y; Mitsuyama Y; Meguro K; Ikeda M;
    J Alzheimers Dis; 2015; 45(2):543-52. PubMed ID: 25589723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Martinez-Torteya A; Gomez-Rueda H; Trevino V; Farber J; Tamez-Pena J; For The Alzheimer's Disease Neuroimaging Initiative
    Curr Alzheimer Res; 2018; 15(8):751-763. PubMed ID: 29422002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
    J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
    Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
    Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors.
    Cui Y; Liu B; Luo S; Zhen X; Fan M; Liu T; Zhu W; Park M; Jiang T; Jin JS;
    PLoS One; 2011; 6(7):e21896. PubMed ID: 21814561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk classification in mild cognitive impairment patients for developing Alzheimer's disease.
    Zhou B; Nakatani E; Teramukai S; Nagai Y; Fukushima M;
    J Alzheimers Dis; 2012; 30(2):367-75. PubMed ID: 22426014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment.
    Habert MO; Horn JF; Sarazin M; Lotterie JA; Puel M; Onen F; Zanca M; Portet F; Touchon J; Verny M; Mahieux F; Giron A; Fertil B; Dubois B
    Neurobiol Aging; 2011 Jan; 32(1):15-23. PubMed ID: 19250707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment.
    Schmand B; Eikelenboom P; van Gool WA;
    J Alzheimers Dis; 2012; 29(3):641-8. PubMed ID: 22297644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How early can we predict Alzheimer's disease using computational anatomy?
    Adaszewski S; Dukart J; Kherif F; Frackowiak R; Draganski B;
    Neurobiol Aging; 2013 Dec; 34(12):2815-26. PubMed ID: 23890839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.